BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7521958)

  • 1. Test pest.
    Hammond P
    Nurs Times; 1994 Aug 10-16; 90(32):60. PubMed ID: 7521958
    [No Abstract]   [Full Text] [Related]  

  • 2. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM; Dupuis HM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk estimation in Down's syndrome screening.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1996 Nov; 16(11):1055-7. PubMed ID: 8953642
    [No Abstract]   [Full Text] [Related]  

  • 4. [Triple test: problem or enhancement of prenatal diagnosis].
    Rauskolb R; Engel W
    Z Geburtshilfe Neonatol; 1995; 199(3):91. PubMed ID: 7553260
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal detection of Down syndrome.
    Smith CV
    Nebr Med J; 1995 Aug; 80(8):268-70. PubMed ID: 7566251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early pregnancy serum screening in Helsinki: results and mothers' opinions].
    Salonen R; Turpeinen U; Kurki L; Lappalainen M; Ammälä P; Hiilesmaa V; Teramo K; von Koskull H; Gahmberg N; Stenman UH
    Duodecim; 1997; 113(24):2548-55. PubMed ID: 10892162
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comment on the contribution by Benz et al.: Serum screening for Down syndrome in women under 35 years of age with an age independent index].
    Reynolds T; Pistorius K; Spencer K; John R
    Z Geburtshilfe Neonatol; 1995; 199(3):128-9. PubMed ID: 7553259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study].
    Aymé S; Aurran Y; Chabal F; Gombert A; Loundou H; Montfort C; Sollier M; Silvestri A
    Contracept Fertil Sex; 1993 Feb; 21(2):133-43. PubMed ID: 7524931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical screening.
    Cuckle HS; Wald NJ
    Curr Opin Obstet Gynecol; 1990 Apr; 2(2):246-52. PubMed ID: 1714781
    [No Abstract]   [Full Text] [Related]  

  • 10. Making sense of maternal serum screening.
    Lindsay P
    Nurs Times; 1994 Dec 7-14; 90(49):30-2. PubMed ID: 7528377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Triple screening for trisomy 21: prospective results of 7039 assessments].
    Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
    Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple marker screening in native Japanese women.
    Onda T; Kitagawa M; Takeda O; Sago H; Kubonoya K; Iinuma K; Bradley LA; Canick JA; Krasikov NE; Ponting NR; Grier RE
    Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence rate of Down's syndrome in Karachi resident women.
    Rahman S; Obaid-ur-Rahman M
    Pak J Pharm Sci; 2005 Apr; 18(2):61-3. PubMed ID: 16431402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Down syndrome: the Jerusalem experience.
    Bach G; Ben-Neriah Z; Sagi M
    Isr J Med Sci; 1993 Aug; 29(8):468-70. PubMed ID: 7691779
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal serum screening.
    Carroll JC
    Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
    Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
    J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.